14 results
8-K
EX-99.1
PVCT
Provectus Biopharmaceuticals, Inc.
28 Oct 14
Regulation FD Disclosure
12:00am
multidisciplinary patient care and practice management; 3) providing relevant cancer education and research training materials using print
424B3
PVCT
Provectus Biopharmaceuticals, Inc.
16 Apr 13
Prospectus supplement
12:00am
. Additionally, Dr. McMasters serves as chairman of our scientific advisory board. Dr. McMasters received his undergraduate training at Colgate … particular background and circumstances, including training and prior relevant work experience;
the individual’s role with us and the compensation paid
424B3
hhd36h2gcbm7nqik84ws
5 Apr 10
Prospectus supplement
12:00am
10-K
axzi9qqh3 gdxded
31 Mar 09
Annual report
12:00am
8-K
fkbt1lb57emr j9wnx
5 Jun 08
Provectus Pharmaceuticals Appoints Kelly M. McMasters, MD, PhD, to Board of Directors
12:00am
8-K
EX-99.1
4dfleof5212fgnfffy
5 Jun 08
Provectus Pharmaceuticals Appoints Kelly M. McMasters, MD, PhD, to Board of Directors
12:00am
8-K
1sfzpy176d4x2 ms
20 Dec 02
Acquisition or disposition of assets
12:00am
- Prev
- 1
- Next